Regulatory News Archives - Scancell

Interim Results and Business Update

by chantal | Jan 29, 2026 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma

by chantal | Jan 26, 2026 | Latest News, News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Notice of Interim Results and Investor Presentation

by chantal | Jan 22, 2026 | Latest News, News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+

by chantal | Dec 9, 2025 | iSCIB1+, Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell to present positive Phase 2 data on Immunobody^® iSCIB1+ in late-stage melanoma at SITC 2025

by chantal | Nov 7, 2025 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Results of 2025 Annual General Meeting

by alex | Oct 30, 2025 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

« Older Entries